BlackRock’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,754,966
Closed -$1.15B 5652
2025
Q1
$1.15B Buy
8,754,966
+2,642,243
+43% +$329M 0.02% 561
2024
Q4
$511M Sell
6,112,723
-106,354
-2% -$8.74M 0.01% 1073
2024
Q3
$455M Sell
6,219,077
-102,542
-2% -$7.71M 0.01% 1147
2024
Q2
$433M Sell
6,321,619
-1,756,139
-22% -$122M 0.01% 1100
2024
Q1
$559M Sell
8,077,758
-115,786
-1% -$7.96M 0.01% 948
2023
Q4
$587M Buy
8,193,544
+678,693
+9% +$39M 0.02% 886
2023
Q3
$391M Sell
7,514,851
-76,216
-1% -$4.44M 0.01% 1069
2023
Q2
$481M Buy
7,591,067
+322,235
+4% +$20.1M 0.01% 957
2023
Q1
$394M Sell
7,268,832
-181,329
-2% -$8.77M 0.01% 1078
2022
Q4
$394M Buy
7,450,161
+348,111
+5% +$17.4M 0.01% 1047
2022
Q3
$330M Buy
7,102,050
+53,693
+0.8% +$2.8M 0.01% 1106
2022
Q2
$402M Buy
7,048,357
+577,940
+9% +$32.8M 0.01% 1011
2022
Q1
$396M Buy
6,470,417
+748,651
+13% +$38.9M 0.01% 1149
2021
Q4
$299M Sell
5,721,766
-14,630
-0.3% -$615K 0.01% 1428
2021
Q3
$214M Buy
5,736,396
+17,547
+0.3% +$610K 0.01% 1662
2021
Q2
$233M Sell
5,718,849
-439,284
-7% -$16.2M 0.01% 1648
2021
Q1
$209M Buy
6,158,133
+259,565
+4% +$9M 0.01% 1701
2020
Q4
$188M Buy
5,898,568
+626,352
+12% +$16.5M 0.01% 1671
2020
Q3
$135M Buy
5,272,216
+265,274
+5% +$6.05M 0.01% 1687
2020
Q2
$129M Buy
5,006,942
+569,157
+13% +$11.5M 0.01% 1677
2020
Q1
$68.2M Buy
4,437,785
+527,274
+13% +$11.5M ﹤0.01% 1883
2019
Q4
$134M Sell
3,910,511
-66,520
-2% -$798K 0.01% 1776
2019
Q3
$29.7M Buy
3,977,031
+43,757
+1% +$420K ﹤0.01% 2589
2019
Q2
$51.1M Buy
3,933,274
+84,063
+2% +$1.08M ﹤0.01% 2302
2019
Q1
$46.9M Sell
3,849,211
-155,455
-4% -$1.99M ﹤0.01% 2315
2018
Q4
$45.6M Buy
4,004,666
+76,356
+2% +$1.23M ﹤0.01% 2295
2018
Q3
$85.2M Buy
3,928,310
+133,324
+4% +$2.79M ﹤0.01% 2066
2018
Q2
$67.1M Buy
3,794,986
+41,856
+1% +$850K ﹤0.01% 2188
2018
Q1
$79M Sell
3,753,130
-249,790
-6% -$4.87M ﹤0.01% 1994
2017
Q4
$58M Buy
4,002,920
+709,048
+22% +$10.9M ﹤0.01% 2193
2017
Q3
$52M Sell
3,293,872
-541,879
-14% -$7.95M ﹤0.01% 2270
2017
Q2
$47.6M Buy
3,835,751
+260,768
+7% +$3.02M ﹤0.01% 2294
2017
Q1
$58.1M Buy
3,574,983
+3,560,178
+24,047% +$51.5M ﹤0.01% 2126
2016
Q4
$223K Buy
14,805
+590
+4% +$8.33K ﹤0.01% 2078
2016
Q3
$216K Sell
14,215
-89,814
-86% -$3.63M ﹤0.01% 2114
2016
Q2
$4.04M Buy
104,029
+1,455
+1% +$52.3K 0.01% 932
2016
Q1
$2.85M Buy
102,574
+1,048
+1% +$34.9K ﹤0.01% 997
2015
Q4
$5.46M Sell
101,526
-14,488
-12% -$731K 0.01% 824
2015
Q3
$4.65M Buy
116,014
+76,900
+197% +$2.51M 0.01% 808
2015
Q2
$1.25M Sell
39,114
-58,200
-60% -$1.48M ﹤0.01% 1275
2015
Q1
$2.32M Hold
97,314
﹤0.01% 1040
2014
Q4
$1.72M Hold
97,314
﹤0.01% 1087
2014
Q3
$1.33M Sell
97,314
-7,900
-8% -$119K ﹤0.01% 1150
2014
Q2
$1.77M Buy
105,214
+414
+0.4% +$6.84K ﹤0.01% 1068
2014
Q1
$1.91M Buy
+104,800
New +$1.89M ﹤0.01% 1062

Other funds holding ITCI